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Abstract
Aims and background: Old age is associated with comorbidity and decreased functioning which influences
treatment decisions in elderly breast cancer patients. The purpose of this study was to identify risk factors for
complications after breast cancer surgery in elderly patients, and to assess mortality in patients with postoperative
complications.
Methods: We retrospectively considered all female patients aged 65 years and older with invasive and in situ
breast cancer who were diagnosed and treated between 1997 and 2012 in the Department of General and
Geriatric Surgery of the University of Naples “Federico II”.
Results and conclusion: 449 patients received surgery, of whom 18,2% (n = 82) developed one or more
postoperative complications. The odds ratio of having postoperative complications show an increase with age,
reaching statistical significance only for patients older than 85 [OR 5,75 (95% confidence interval 2,38-14,04); p <
0,001]. Number of concomitant diseases [OR 2,51 (95% CI 1,17 - 5,45); p = 0,01 for 3 or more concomitant diseases]
and polypharmacy [OR 16,7 (95% CI 9,12 - 30,58); p < 0,0001) are associated to an increased risk of postoperative
complications. Overall survival was worse in patients with postoperative complications [HR 2,06 (95% CI 1,52-2,70),
p < 0,001]. This increased risk of mortality is probably due to geriatric parameters such as comorbidity or poor
physical function, more than to higher complication rates.
Introduction
In developed countries, 40% of breast cancer patients are
older than 65 years of age at diagnosis and this percentage
is increasing [1]. Old age is predictive for comorbidity and
decreased functioning [2,3]. Therefore, these factors might
influence treatment decisions in elderly breast cancer
patients. Previous studies have shown that elderly breast
cancer patients receive less aggressive treatment [4] and
have a higher disease-specific mortality, even with 65% of
breast cancer patients above 75 years dying from other
causes than breast cancer [5].
The most recent guidelines of the International
Society of Geriatric Oncology and the European Society
of Breast Cancer Specialists (EUSOMA) advise breast
conserving surgery with whole-breast radiotherapy or
mastectomy followed by postoperative radiotherapy in
selected patients as standard care for elderly breast can-
cer patients [6]. However, the National Comprehensive
Cancer Network guidelines state that omission of radio-
therapy may be considered in patients of 70 years or
older with stage I estrogen receptor-positive breast can-
cer who undergo a lumpectomy with negative margins
and are receiving endocrine therapy [7]. This shows that
there is still no consensus on how to treat elderly breast
cancer patients. Also, elderly patients are often not trea-
ted according to guidelines [8,9]. Comorbid conditions
and frailty are, besides age and patient and physician’s
preference, important reasons to deviate from the guide-
lines [10,11]. Besides, treatment strategies for elderly
breast cancer patients are mostly not evidence-based
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because elderly are often not included in clinical trials
due to age restrictions or comorbidity [12].
Breast surgery is generally considered as low-morbidity
surgery [13]. However, a variety of complications can
occur with serious consequences. For example, surgical
site infections can lead to increased morbidity, additional
costs and delay of postoperative adjuvant therapies [13].
In order to develop evidence-based guidelines for tai-
lored care of breast cancer in the elderly, it is important
to investigate the occurrence of complications of surgery
in this specific group. Only few studies concerning post-
operative complications in elderly breast cancer patients
have been performed, often with a limited number of
patients [11,14,15]. Therefore, the objective of this study
was to identify risk factors for postoperative complica-
tions in elderly breast cancer patients, and to evaluate
overall survival in patients with postoperative complica-
tions compared with patients without postoperative
complications.
Methods
We considered all consecutive female patients aged 65
years and older with invasive and in situ breast cancer
who were diagnosed and treated between 1997 and 2012
in the Department of General and Geriatric Surgery of
the University of Naples “Federico II”.
We reviewed the charts of these patients and collected
information on specific treatments, comorbidities,
adverse events, geriatric parameters, body mass index
(BMI), smoking and mortality.
For this study, all patients with breast cancer stage I-IV
and in situ of all histological subtypes who were treated
with breast conserving surgery or mastectomy were
included. If patients received breast-conserving surgery
(BCS) followed by mastectomy, the most extensive sur-
gery was used for analyses. Stage was described using the
pathological tumor-node-metastasis (TNM) classifica-
tion, as valid in the year of diagnosis. If the pathological
stage was missing, clinical stage was used. Axillary
surgery was defined as a sentinel node procedure or an
axillary lymph node dissection. Again, the most extensive
axillary surgery was used for the analyses.
To compare different age groups, patients were cate-
gorized into five groups: 65-69, 70-74, 75-79, 80-84, and
85 years or older.
Number of concomitant diseases was categorized in
four groups: no concomitant disease, 1 concomitant dis-
ease, 2 concomitant diseases and 3 or more concomitant
diseases [16]. BMI was analyzed in three groups: <20,
20-25, and >25.
In case of missing data, patients were not excluded from
the analyses, but analyzed in a separate group (unknown).
The possible postoperative complications were wound
infections (including abscesses), bleeding, hematoma,
seroma, anemia, cardiovascular complications, thrombo-
embolisms and other complications. The primary out-
come was defined as having one or more of these
complications.
Statistical analyses
All statistical analyses were two-sided. A p value smaller
than 0.05 was considered as significant.
The following risk factors for having at least one post-
operative complication were assessed in univariable
logistic regression models: age (in groups per 5 years),
stage according to the TNM-classification, most exten-
sive surgery, most extensive axillary surgery, number of
comorbid conditions, polypharmacy (5 or more types of
drugs per day), neoadjuvant treatment, BMI, and smok-
ing at time of surgery.
Results
Patient characteristics
Overall, 449 patients of 65 years and older with invasive
and in situ breast cancer underwent BCS or mastectomy
and were included for analyses. Patient characteristics
are shown in Table 1.
Most patients (72%) were treated with mastectomy.
The majority of patients (74.8%) had at least one conco-
mitant disease. Few patients (3.0%) received neoadjuvant
treatment. 21% of the patients used 5 or more types of
drugs per day. BMI values were missing in 224 patients
(49.8%) and data about smoking were missing in 142
patients (31.6%). Median follow up was 7.5 years (range
0.01 -15.0).
Postoperative complications
Overall, 18.2% of patients developed 1 or more post-
operative complications (Table 2). The most frequent
complications were seroma (n = 21) and wound infec-
tion (n = 17).
As shown in Table 3, the odds ratio (OR) for develop-
ing a postoperative complication increased with age (OR
for patients aged > 85 years was 5.75 (95% confidence
interval 2.38-14.04, p < 0.001) in a univariable logistic
regression model).
A higher number of concomitant diseases was asso-
ciated with a higher risk of postoperative complications
(patients without concomitant disease functioned as a
reference; OR was 1.67 (95% CI 0.74-3.80), 1.79 (95% CI
0.80-4.07) and 2.51 (95% CI 1.17-5.45; p = 0.01) in
patients with 1, 2 and 3 or more concomitant diseases,
respectively).
Similarly, polypharmacy was strongly associated with
risk of complications (OR 16.7 (95% CI 9.12-30.58), p <
0.0001).
Furthermore, patients who received a mastectomy and
patients who underwent axillary lymph node dissection
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had more complications than patients who were treated
with breast conserving surgery and less extensive axillary
surgery.
Smoking increased the odds for developing a compli-
cation with an OR of 2.75 (95% CI 1.14-6.54, p < 0.05).
There was no significant association between BMI and
postoperative complications.
Overall survival was worse in patients with postopera-
tive complications [HR 2,06 (95% CI 1,52-2,70), p <
0,001] (Table 4). This increased risk of mortality is
probably due to geriatric parameters such as comorbid-
ity or poor physical function, more than to higher com-
plication rates.
Discussion
This study shows that the number of concomitant dis-
eases and polypharmacy are strongly related to the
occurrence of postoperative complications in elderly
breast cancer patients.
Patients treated with mastectomy had more complica-
tions than patients who received breast conserving
surgery.
Elderly patients had complications more often, but
after adjustment for tumor stage, comorbidity, and treat-
ment, only a trend for increasing risk of complications
in higher age groups was observed.
Overall survival was worse in patients with one or
more postoperative complications.
The increased risk for early and late overall mortality
is probably not due to the complications in itself, but
can be explained by the frail state of the patients who
develop postoperative complications, since comorbidity
in itself increases the risk of mortality in elderly breast
cancer patients [17,18].
Concerning the impact of comorbidity on developing
postoperative complications, Houterman et al. [15] con-
cluded from an observational study that comorbidity
and age did not influence the occurrence of complica-
tions after treatment. The study included only 154
patients aged 70 years or older, and investigated compli-
cations of all types of therapy in the first year after diag-
nosis. Also, patients who did not receive surgery were
included in this study. Therefore, this study differs con-
siderably from the current study, which might explain
the differences in outcome. Another study by Janssen-
Heijnen et al. [14] also found no association between
comorbidity and postoperative complications. Again,
this study included only 490 patients with breast cancer,
of whom only 192 were older than 65. Since the impact
of comorbid disease is the highest in the eldest elderly,
this might explain the differences with the current
study.
A recent Danish study [19] found that older age and
mastectomy increases the risk of re-operation due to
bleeding in breast cancer surgery. These results were
confirmed in the current study.
Another study [20] found that BMI > 25, diabetes, and
smoking were predictors of wound complications. In the
current study, BMI was not related to risk of postoperative
Table 1 Patients characteristics.
PATIENTS’ CHARACTERISTICS n (449) %
MEDIAN AGE (range) 76.0 (65-92)
AGE
65-69 131 29,5%
70-74 114 25,1%
75-79 87 19,3%
80-84 68 15,2%
>85 49 10,9%
N OF CONCOMITANT DISEASE
0 113 25,2%
1 112 25,0%
2 106 23,6%
> = 3 118 26,2%
TNM STAGE
IN SITU 17 3,9%
I 168 37,5%
II 180 40,1%
III 39 8,8%
IV 4 1,0%
UNKNOWN 41 8,7%
NEOADJUVANT TREATMENT
NO NEOADJUVANT TREATMENT 436 97%
NEOADJUVANT CHEMOTHERAPY 13 3%
BREAST SURGERY
BREAST CONSERVING SURGERY 125 28%
MASTECTOMY 324 72%
AXILLARY SURGERY
NO AXILLARY SURGERY 40 9%
SENTINEL NODE BIOPSY 180 40%
AXILLARY LYMPH NODE DISSECTION 229 51%
BMI
<20 4 1%
20-25 86 19,1%
>25 135 30,1%
UNKNOWN 224 49,8%
POLYPHARMACY
NO 354 79%
YES 95 21%
SMOKING AT TIME OF DIAGNOSIS
NO 276 61,5%
YES 31 6,9%
UNKNOWN 142 31,6%
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Table 2 Complications in different age groups.
TOTAL 65-69 70-74 75-79 80-84 > = 85
ALL COMPLICATIONS 82 (18,2%) 13 (9,9%) 15 (13,2%) 17 (19,5%) 18 (26,5%) 19 (38,8%)
WOUND INFECTION 17 (3,8%) 3 4 4 3 3
BLEEDING 14 (3,2%) 4 2 2 3 3
HEMATOMA 14 (3,2%) 3 2 4 3 2
SEROMA 21 (4,8%) 2 4 5 4 6
ANEMIA 2 (0,4%) 0 0 0 1 1
CARDIOVASCULAR COMPLICATION 8 (1,4%) 0 2 2 2 2
THROMBO-EMBOLISM 4 (1,0%) 1 1 0 1 1
OTHER COMPLICATIONS 2 (0,4%) 0 0 0 1 1
Table 3 Association between patient, tumor characteristics, treatment and occurrence of postoperative complications.
N OF PATIENTS WITH COMPLICATION (%) OR 95% CI p value
AGE
65-69 13 (9,9%) Ref
70-74 15 (13,2%) 1,37 0,58-3,24 ns
75-79 17 (19,5%) 2,20 0,95-5,16 ns
80-84 18 (26,5%) 3,27 1,40-7,72 0,004
> = 85 19 (38,8%) 5,75 2,38-14,04 <0,001
N OF CONCOMITANT DISEASE
0 13 (12,0%) Ref
1 20 (18,3%) 1,67 0,74-3,80 ns
2 20 (18,5%) 1,79 0,80-4,07 ns
> = 3 29 (24,6%) 2,51 1,17-5,45 0,01
POLYPHARMACY
NO 27 (7,6%) Ref
YES 55 (57,9%) 16,65 9,12-30,58 <0.0001
BREAST SURGERY
BREAST CONSERVING SURGERY 29 (23,2%) Ref
MASTECTOMY 53 (16,4%) 0.65 0,38-1,11 ns
AXILLARY SURGERY
NO AXILLARY SURGERY 5 (12,5%) Ref
SENTINEL NODE BIOPSY 31 (17,2%) 1,46 0,49-4.60 ns
AXILLARY LYMPH NODE DISSECTION 46 (20,1%) 1,76 0,61-5,43 ns
NEOADJUVANT CHEMOTHERAPY
NO NEOADJUVANT TREATMENT 76 (17,4%) Ref
NEOADJUVANT CHEMOTHERAPY 6 (46,1%) 4,06 1,17-13,92 <0,05
TNM STAGE
IN SITU 4 (23,5%)
I 27 (16,1%) Ref
II 25 (13,9%) 0,84 0,45-1,58 ns
III 8 (20,5%) 1,35 0,51-3,49 ns
IV 1 (25%) 1,74 0,07-19,99 ns
UNKNOWN 17 (41,5%)
BMI
<20 1 (25%) 2,06 0,08-25,85 ns
20-25 12 (14%) Ref
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complications, which might be explained by missing values
in about 50% of patients, since BMI registration in a chart
may not be missing at random.
Since elderly patients are rarely included in clinical
trials [12], large cohort studies are of great importance in
this population. These studies are a good way of studying
complications of treatment, since data are unbiased and
the studies generally contain more patients [21].
This study also has some limitations. Due to the retro-
spectively collection of data, there might have been an
underestimation of the number of complications. How-
ever, in these data, 18.2% of patients developed at least
one complication, and this is even higher than a recent
study in a large cohort in the U.S. [20] which reported a
30-day morbidity rate for all breast cancer procedures of
5.6%. The most common complications were wound
infections. Therefore, these data seem to accurately reflect
general practice and correspond with previous studies.
A meta-analysis has confirmed that hormonal treat-
ment as monotherapy is inferior to surgery (with or
without hormonal treatment) for the local control and
progression-free survival of breast cancer in medically fit
older women [22-25].
However, in Italy, elderly patients receive less surgery
and more hormonal therapy as monotherapy than
younger patients, even in lower stages of disease [4].
This suggests that patients might be undertreated due to
fear of morbidity and mortality in breast cancer surgery.
Although elderly patients with comorbidity do have a
higher risk of postoperative complications, relative mortal-
ity was not higher in this group and therefore suggests
that omitting surgery because of fear for treatment-related
mortality is only justified in vulnerable elderly patients.
The question remains how to identify this specific group.
Therefore, future prospective studies are needed to
identify patients at risk for postoperative complications,
and to develop tailored care for elderly breast cancer
patients.
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Table 4 Survival analyses for one or more postoperative complications versus no postoperative complications.
DEATHS 5-YEAR SURVIVAL (%) HR 95% CI p value
OVERALL SURVIVAL 133 70
No postoperative complications 91 75 Ref
Postoperative complications 42 49 2,06 1,52-2,70 < 0,001
Table 3 Association between patient, tumor characteristics, treatment and occurrence of postoperative complications.
(Continued)
>25 31 (23%) 1,84 0,84-4,08 ns
UNKNOWN 38 (17%)
SMOKING AT TIME OF DIAGNOSIS
NO 46 (16,7%) Ref
YES 11 (35,5%) 2,75 1,14-6,54 <0,05
UNKNOWN 25 (17,6%)
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